Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW)
TWD 33.25
(-1.77%)
TWD 33.25
(-1.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.08 Billion | 2.11 Billion | 1.93 Billion | 1.54 Billion | 1.15 Billion | 1.01 Billion |
| Cost of Revenue | 1.32 Billion | 1.15 Billion | 985.31 Million | 856.83 Million | 688.01 Million | 667.94 Million |
| Gross Profit | 757.3 Million | 961.75 Million | 949.38 Million | 686.75 Million | 468.62 Million | 351.51 Million |
| Operating Expenses | 437.58 Million | 516.57 Million | 492.56 Million | 417.83 Million | 347.52 Million | 320.61 Million |
| Selling, General and Administrative Expenses | 194.88 Million | 271.78 Million | 239.89 Million | 202.1 Million | 152.06 Million | 159.08 Million |
| Research and Development Expenses | 242.69 Million | 244.78 Million | 252.67 Million | 215.72 Million | 195.46 Million | 161.53 Million |
| Other Expenses | -1.00 | 73.87 Million | 12.17 Million | 347.81 Million | 5.03 Million | 218.73 Million |
| Cost and Expenses | 1.8 Billion | 1.67 Billion | 1.47 Billion | 1.27 Billion | 1.03 Billion | 988.56 Million |
| Operating Income | 280.8 Million | 574.67 Million | 519.27 Million | 655.05 Million | 154.36 Million | 30.89 Million |
| Interest Expense | 19.43 Million | 9.71 Million | 3.32 Million | 4.75 Million | 10.61 Million | 10.87 Million |
| Income Tax Expense | 68.57 Million | 117.16 Million | 96.56 Million | 118.23 Million | 26.61 Million | 5.95 Million |
| Earnings before Tax | 333.48 Million | 583.3 Million | 497.61 Million | 650.29 Million | 143.74 Million | 240.24 Million |
| Net Income | 264.9 Million | 465.86 Million | 400.77 Million | 531.87 Million | 117 Million | 234.25 Million |
| Earnings Per Share Basic | 3.42 | 6.01 | 5.17 | 6.86 | 1.51 | 3.02 |
| Earnings Per Share Diluted | 3.39 | 5.93 | 5.12 | 6.79 | 1.50 | 2.99 |
| Weighted Average Shares Outstanding | 77.56 Million | 77.56 Million | 77.56 Million | 77.56 Million | 77.56 Million | 77.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 78.09 Million | 78.5 Million | 78.31 Million | 78.33 Million | 78.2 Million | 78.32 Million |
| Gross Margin | 0.36 | 0.45 | 0.49 | 0.44 | 0.41 | 0.34 |
| EBIT Margin | 0.23 | 0.35 | 0.34 | 0.51 | 0.25 | 0.38 |
| Profit Margin | 0.13 | 0.22 | 0.21 | 0.34 | 0.10 | 0.23 |
| EBITDA | 473.81 Million | 743.72 Million | 651.27 Million | 786.2 Million | 250.75 Million | 165.73 Million |
| Earnings Before Tax Margin | 0.13 | 0.27 | 0.27 | 0.42 | 0.13 | 0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 461.15 Million | 251.71 Million | 2.08 Billion | 455.48 Million | 339.06 Million | 526.44 Million |
| Cost of Revenue | 353.89 Million | 145.3 Million | 1.36 Billion | 315.08 Million | 237.41 Million | 370.12 Million |
| Gross Profit | 107.26 Million | 106.4 Million | 718.39 Million | 140.4 Million | 101.64 Million | 156.31 Million |
| Operating Expenses | 83.82 Million | 92.07 Million | 437.58 Million | 87.09 Million | 110.17 Million | 126.04 Million |
| Selling, General and Administrative Expenses | 36.39 Million | 40.25 Million | - | 31.11 Million | 46.12 Million | 64.16 Million |
| Research and Development Expenses | 47.43 Million | 51.82 Million | - | 55.97 Million | 64.04 Million | 61.87 Million |
| Other Expenses | 203 Thousand | 22.17 Million | 28.34 Million | -14.29 Million | 16.14 Million | 15.73 Million |
| Cost and Expenses | 437.71 Million | 237.38 Million | 1.8 Billion | 402.18 Million | 347.59 Million | 496.16 Million |
| Operating Income | 23.44 Million | 14.33 Million | 280.8 Million | 53.3 Million | 16.92 Million | 52.52 Million |
| Interest Expense | 5.92 Million | 5.7 Million | 19.43 Million | 5.81 Million | 4.52 Million | 4.7 Million |
| Income Tax Expense | 8.95 Million | 5.4 Million | 68.57 Million | 5.48 Million | 566 Thousand | 18.22 Million |
| Earnings before Tax | 19.1 Million | 32.08 Million | 296.98 Million | 35.05 Million | 12.4 Million | 47.82 Million |
| Net Income | 21.07 Million | 40.55 Million | 264.9 Million | 44.22 Million | 11.83 Million | 29.6 Million |
| Earnings Per Share Basic | 0.27 | 0.52 | - | 0.57 | 0.15 | 0.38 |
| Earnings Per Share Diluted | 0.27 | 0.52 | - | 0.57 | 0.15 | 0.38 |
| Weighted Average Shares Outstanding | 77.56 Million | 77.56 Million | 77.56 Million | 77.56 Million | 77.56 Million | 77.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 77.61 Million | 77.99 Million | 78.09 Million | 77.56 Million | 78.17 Million | 77.81 Million |
| Gross Margin | 0.23 | 0.42 | 0.34 | 0.31 | 0.30 | 0.30 |
| EBIT Margin | 0.16 | 0.26 | - | 0.22 | 0.19 | 0.19 |
| Profit Margin | 0.05 | 0.16 | 0.13 | 0.10 | 0.03 | 0.06 |
| EBITDA | 73.53 Million | 64.36 Million | - | 101.1 Million | 65.21 Million | 101.15 Million |
| Earnings Before Tax Margin | 0.05 | 0.06 | 0.13 | 0.12 | 0.05 | 0.10 |
PEL
VLEGOV
MGDDY
CLI
S59
6194